1. Home
  2. OPEN vs PBLS Comparison

OPEN vs PBLS Comparison

Compare OPEN & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opendoor Technologies Inc

OPEN

Opendoor Technologies Inc

N/A

Current Price

$2.38

Market Cap

3.5B

Sector

Finance

ML Signal

N/A

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$30.44

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPEN
PBLS
Founded
2014
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.6B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
OPEN
PBLS
Price
$2.38
$30.44
Analyst Decision
Hold
Strong Buy
Analyst Count
9
5
Target Price
$4.27
★ $41.75
AVG Volume (30 Days)
★ 24.3M
679.6K
Earning Date
11-05-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $4,371,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$90.44
$222.58
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.37
$25.56
52 Week High
$9.69
$42.49

Technical Indicators

Market Signals
Indicator
OPEN
PBLS
Relative Strength Index (RSI) 27.36 39.57
Support Level N/A $26.42
Resistance Level $2.81 $33.65
Average True Range (ATR) 0.11 3.16
MACD 0.00 -0.72
Stochastic Oscillator 2.68 20.05

Price Performance

Historical Comparison
OPEN
PBLS

About OPEN Opendoor Technologies Inc

Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital-light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: